Filing Details
- Accession Number:
- 0001209191-19-012808
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-22 21:34:59
- Reporting Period:
- 2019-02-22
- Accepted Time:
- 2019-02-22 21:34:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1331852 | S Joseph Zakrzewski | C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-02-22 | 143,750 | $8.86 | 228,297 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-02-22 | 36,875 | $8.10 | 265,172 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-02-22 | 180,625 | $19.90 | 84,547 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2019-02-22 | 143,750 | $0.00 | 143,750 | $8.86 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2019-02-22 | 36,875 | $0.00 | 36,875 | $8.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-02-01 | No | 4 | M | Direct | |
| 0 | 2023-01-02 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- The stock option granted to the Reporting Person is fully vested as of the date hereof.
Billionaire Hedge Funds
